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ABSTRACT
Phenylethanolamine-N-methyltransferase (Pnmt) catalyzes the conversion of
noradrenaline to adrenaline and is the last enzyme in the catecholamine biosynthetic pathway.
Pnmt serves as a marker for adrenergic cells, and lineage-tracing experiments have identified the
embryonic heart and hindbrain region as the first sites of Pnmt expression in the mouse. Pnmt
expression in the heart occurs before the adrenal glands have formed and prior to sympathetic
innervation, suggesting that the heart is the first site of catecholamine production in the mouse.
The function of these Pnmt+ cells in heart development remains unclear. In the present study, we
test the hypothesis that (i) a genetic ablation technique utilizing a suicide reporter gene
selectively destroys Pnmt cells in the mouse, and (ii) Pnmt cells are required for normal
cardiovascular and neurological function.
To genetically ablate adrenergic cells, we mated Pnmt-Cre mice, in which Crerecombinase is under the transcriptional regulation of the Pnmt promoter, and a Cre -activated
diphtheria toxin A (DTA) mouse strain (ROSA26-eGFP-DTA), thereby causing activation of the
toxic allele (DTA) in Pnmt-expressing (adrenergic) cells resulting in selective “suicide” of these
cells in approximately half of the offspring. The other half serve as controls because they do not
have the ROSA26-eGFP-DTA construct. In the Pnmt+/Cre; R26+/DTA offspring, we achieve a
dramatic reduction in Pnmt transcript and Pnmt immunoreactive area in the adrenal glands.
Furthermore, we show that loss of Pnmt cells results in severe left ventricular dysfunction that
progressively worsens with age. These mice exhibit severely reduced cardiac output and ejection
fraction due to decreased LV contractility and bradycardia at rest. Surprisingly, these mice
appear to have a normal stress response, as heart rate and ejection fraction increased to a similar
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extent compared to controls. In addition to baseline cardiac dysfunction, these mice fail to gain
body weight in a normal manner and display gross neurological dysfunction, including muscular
weakness, abnormal gaiting, and altered tail suspension reflex, an indicator of neurological
function.
This work demonstrates that selective Pnmt cell destruction leads to severe left
ventricular dysfunction, lack of weight gain, and neurological dysfunction. This novel mouse is
expected to shed insight into the role of Pnmt cells in the heart, and suggests a role for Pnmt cells
in neurological regulation of feeding behavior, metabolism, and motor control.
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INTRODUCTION
Extra-Adrenal Sites of Pnmt Expression
Pheynlethanolamine-N-methyltransferase (Pnmt) performs the final catalytic step in the
biosynthesis of adrenaline, methylating noradrenaline with a methyl group from the donor Sadenosylmethionine. Pnmt is primarily expressed in the adrenal glands in the adult, but many
extra-adrenal sites of Pnmt expression have been identified, including the heart, brain, kidneys,
and adipose tissue (Kvetnansky et al., 2012) (Spatz et al., 1982) (Ebert et al., 1996) (Ebert et al.,
2008) (Ziegler et al., 1989) [for review, see – (Ziegler et al., 2002)].
Pnmt Expression in the Embryonic Heart
The first site of Pnmt expression in mouse and rat is the embryonic heart and hindbrain
region (Ebert et al., 1996) (Ebert et al., 2008) (Ebert et al., 2004). In the rat, Pnmt expression
begins at embryonic day 9.5 (E9.5), peaking at E10.5, and gradually decreasing until it is no
longer detectable by E13.5 (Ebert et al., 1996). Pnmt+ cells were identified in close proximity to
cells of the conduction system, including the sinoatrial node, atrioventricular node, His bundle,
and Purkinje fibers (Ebert and Thompson, 2001) (Ebert et al., 1996). Pnmt has been identified in
various cell types within the heart, including intrinsic cardiac adrenergic cells, cardiac myocytes,
and intracardiac neurons (Huang et al., 1996) (Osuala et al., 2011) (Slavikova et al., 2003).
In order to study the distribution of Pnmt expression, various reporter mice have been
generated (Xia et al., 2013) (Ebert et al., 2004) (Quaife et al., 1994) (Ziegler et al., 2002). Studies
using fluorescent reporter under the Pnmt regulatory sequence have identified Pnmt in the atrium
and ventricle of E10.5 mice and have identified Pnmt expression during differentiation of mouse
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embryonic stem cells to cardiomyocytes (Xia et al., 2013). While these studies are useful to
identify active Pnmt expression, they do not label historical Pnmt expression.
Pnmt Lineage Tracing
Genetic recombination strategies can be used to permanently label cells that expressed a
gene of interest at some point in time. In order to identify active and historical Pnmt expression,
mice expressing Cre-recombinase under transcriptional control of the Pnmt regulatory sequences
(Pnmt-Cre mice) were cross-mated with Rosa26 Reporter mice, which express beta galactosidase
(LacZ) in cells that express Cre-recombinase (Figure 1). Since the Cre-recombinase acts on DNA
in an irreversible manner, beta galactosidase is activated in the cell permanently and is expressed
in all cells derived from the original cell in which Cre-recombinase was expressed. The genetic
schematic shown in Figure 1 outlines this fate-mapping approach achieved through Pnmt-Cre x
Rosa26Reporter mice.
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Figure 1: Overview of Genetics Schematic for Fate Mapping Experiments
Pnmt regulatory sequences drive expression of Cre-recombinase, which removes the floxed stop sequence
immediately upstream of the LacZ gene. LacZ gene is expressed in all cells that expressed Pnmt at some point in
time.

These fate-mapping experiments identified the heart as a major site of Pnmt expression
(Ebert et al., 2004). In the embryonic whole-mount, LacZ staining was identified at E8.5 and
became much more robust by E10.5, primarily labeling the myocardium, brainstem, and 2nd
branchial arch (Figure 2). Between embryonic day 8.5 and 10.5, LacZ staining was identified in
the sinoatrial junction of the heart, in the atrial myocardium, and in the ventricular myocardium.
These results demonstrated that Pnmt+ cells and cells derived from Pnmt+ cells contribute
extensively to development of myocardium and to brain stem.
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Figure 2: Fate-mapping Experiments Identified Extensive LacZ Staining in the E10.5 Mouse Heart.
A) E10.5 embryo of Pnmt-Cre/R26R, B) Control E10.5 embryo of R26R with no Pnmt-Cre. Image taken from Ebert
et al., Developmental Dynamics, 2004.

Furthermore, later studies showed LacZ staining was present in the adult myocardium
(Osuala et al., 2011). Specifically, historical Pnmt expression was identified in the left atrium
and extensively in the free wall of the left ventricle. LacZ staining was heaviest in the left
ventricle, where it was found in cardiomyocytes of the ventral regions of the apex and progressed
towards the base on the dorsal side. Overall, the data provide compelling evidence for the
existence of adult left ventricular myocardium that is derived from Pnmt+ cells. LacZ-stained
cardiomyocytes either expressed Pnmt at some point in time or are derived from progenitors that
expressed Pnmt.
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Figure 3: Lineage-Tracing Stains Historical and Active Pnmt Expression with LacZ.
(A) Pnmt lineage tracing identifies cardiomyocytes at the apex, mid, and base regions of the left ventricle. (B) 3Dimensional reconstruction from serially stained heart indicates extensive LacZ staining throughout the LV
myocardium. Figure taken from Osuala PlosONE 2011, open access.

Overview of Adrenergic Receptors
The actions of adrenaline are mediated by binding to and activating the Beta1, Beta2, and
Alpha1 adrenergic receptors. Activation of the Beta1 adrenergic receptor by adrenaline increases
the rate of contraction (positive chronotropism), the conductivity (positive dromotropism), and
the force of contraction (positive inotropism) in the heart. Activation of Alpha1 receptors induces
smooth muscle contraction and vasoconstriction, while peripheral Beta2 receptor activation
results in smooth muscle relaxation and vasodilation.
The Pnmt Knockout Phenotype
Although Pnmt is extensively expressed in specific areas of the heart, adrenaline
production is not necessary for basal cardiovascular function (Ebert et al., 2004). Mice
5

homozygous for Cre-recombinase (PnmtCre/Cre) lack adrenaline and are born in normal mendelian
ratios, appear normal, and exhibit no overt phenotypes to distinguish them from Pnmt+/Cre
heterozygous controls, which do not lack adrenaline.
Another Pnmt knockout mouse has been previously described (Bao et al., 2007). This
Pnmt knockout was deficient in adrenaline and exhibited normal cardiovascular physiology at
rest. During exercise stress these mice became hypertensive (Bao et al., 2008) and during
restraint stress all cardiovascular indices remained normal, except for a decrease in the ratio of
the left ventricular posterior wall thickness to the left ventricle inner diameter during diastole,
suggesting concentric remodeling (Bao et al., 2007). These mice had normal heart rate and
normal blood pressure at rest.
Ablation of Pnmt+ Cells in the Mouse
Cellular ablation by genetic means is a relatively new tool in elucidation of the
developmental role of specific cell populations. One previous study reported the functional
effects of Pnmt+ cell destruction in mouse (Quaife et al., 1994). In the study, diphtheria toxin
alpha (DTA) gene was under transcriptional control of human Pnmt regulatory sequences. Pnmt+
cell ablation resulted in smaller adrenal glands, small eyes, abnormal lens, and sterility. One
major drawback of this study was that expression of the DTA transgene was not under normal
mouse transcriptional regulation. Rather, 2kb of human Pnmt 5’ upstream region was ligated to
the DTA gene and randomly integrated into mouse oocyte. The effects on cardiovascular system
and behavior were not reported. Furthermore, the DTA gene was under regulatory control of
human Pnmt, rather than mouse Pnmt, so DTA gene expression may not faithfully recapitulate
normal Pnmt expression in the mouse.
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In order to identify the functional role of Pnmt-expressing cells in the heart, we have
utilized a novel cell suicide model to ablate Pnmt+ cells in the developing mouse. Instead of
crossing PnmtCre/Cre mice with R26R Beta Galactosidase reporter mice, they were crossed with
ROSA26-eGFP-DTA mice. These mice express the diphtheria toxin alpha (DTA) subunit upon
activation of Cre-recombinase (Ivanova et al., 2005). This is expected to provide selective and
sensitive ablation of Pnmt+ cells throughout the entire mouse, including the heart. Diphtheria
toxin alpha induces cell death through ADP ribosylation of elongation factor 2, leading to
inhibition of protein synthesis (Collier, 2001) (Evans, 1989). Ivanova et al have estimated that
cells die within 24 hours of endogenous expression of DTA. This system is devised to better
recapitulate normal mouse Pnmt expression. Since Cre-recombinase is knocked-in to exon1 of
the mouse Pnmt gene, it is under normal transcriptional control.
The goals of the present study are to test the hypothesis that: (i) breeding PnmtCre/Cre mice with
ROSA26-eGFP-DTA mice produces selective destruction of Pnmt+ cells and (ii) selective
destruction of Pnmt+ cells results in cardiovascular dysfunction.
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MATERIALS AND METHODS
Mice
All procedures and handling of mice were conducted in accordance with the University
of Central Florida Institutional Animal Care and Use Committees. The PnmtCre/Cre and Rosa26eGFP-DTA mice have been described previously (Ebert et al., 2004) (Ivanova et al., 2005).
PnmtCre/Cre mice were maintained in homozygous conditions, while Rosa26-eGFP-DTA mice
were bred to generate R26+/DTA females. For all experiments described here, PnmtCre/Cre males
were bred with R26+/DTA females to produce offspring that were either Pnmt+/Cre; R26+/+ or
Pnmt+/Cre; R26+/DTA. Mice were genotyped using primers previously described by Ivanova et al
(2008). Pure DNA was isolated from tail snips taken at the time of weaning and PCR was
performed using the following primers: R26R1 5’-AAAGTCGCTCTGAGTTGTTAT-3’, R26R2
5’-GCGAAGAGTTTGTCCTCAACC-3’, and R26R3 5’-GGAGCGGGAGAAATGGATATG3’.
Echocardiography
Transthoracic echocardiography was performed with the VisualSonics Vevo2100
equipped with an MS550 transducer (40MHz) for cardiovascular imaging. Adult mice were
lightly anesthetized with 1.5-2.0% isoflurane to minimize reductions in heart rate. Analysis was
performed on parasternal long axis (PSLA) M mode images of the left ventricle (LV) using
Vevo2100 software v 1.6.0. For all baseline measurements, heart rate was obtained by the Vevo
ECG board. For immobilization echocardiography, mice were first anesthetized, and baseline
recordings taken. Mice were then immobilized on a heated surface in the absence of anesthesia
and allowed to regain consciousness. PSLA recordings of the LV were taken at 1 hour and 2
8

hours after the mouse regained consciousness. For heart rate measurements during restraint, mice
were taped to a pre-warmed tray at 37 degrees Celsius, so ECG could not be obtained with the
Vevo system. Instead, the heart rate trace function of the Vevo software was used to calculate the
heart rate from 8-10 consecutive cardiac cycles. For ultrasound analysis, two independent
observers blinded to genotype performed LV tracing using the Vevo2100 software version 1.6.0.
LV trace measurements were performed on four consecutive cardiac cycles, preferably between
respiratory inspirations to avoid artifacts produced by abdominal cavity movements.
Gene Expression
Fresh tissue was flash-frozen in liquid nitrogen and stored at -80 degrees Celsius. RNA was
isolated from flash-frozen adrenal glands using 1 mL TRIzol reagent. Genomic DNA was
removed by treatment with RNase-free DNase (Promega), recovered by phenol-chloroform
extraction, and genomic DNA contamination was determined by PCR using primers for the
housekeeping gene Gapdh. 400 ng of pure RNA was converted to cDNA using High Capacity
cDNA Reverse Transcription Kit (Invitrogen). Real-time PCR was performed using SYBR
Green Fast reagent in an ABI7500 machine (Applied Biosystems) in 25 uL reactions. Genes of
interest were normalized to the housekeeping gene Glyceraldehyde-3-phosphate Dehydrogenase
(Gapdh). Forward and reverse primers for Pnmt have been described previously and were as
follows: forward 5’-GGTGGCTCAGACCTGAAG-3’ and reverse 5’GCCATCAGGGTTGCTCAG-3’(Xia et al., 2013). Forward and reverse primers for Gapdh were
as follows: forward 5’-AGAGATGATGACCCTTTGGC-3’ and reverse 5’CCATCACCATCTTCCAGGAGCG-3’. The product was detected on a 2% agarose gel to verify
the product size, which was 149 base pairs for Gapdh and 183 base pairs for Pnmt. Relative
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Pnmt gene expression was calculated by delta delta Ct method using Gapdh as endogenous
control and normalized to Pnmt+/Cre; R26+/+ littermates (Schmittgen and Livak, 2008).
Histology
All tissue was fixed overnight in 4% paraformaldehyde at 4 degrees C, washed 3x10
minutes in PBS at room temperature, and then immersed in 30% sucrose in PBS at 4 degrees C.
Tissue was kept in 30% sucrose for at least 2 days to allow it to sink, embedded in optimal
cutting temperature solution, and then cryosectioned. Slides were either stained immediately or
kept at -20 degrees Celsius until staining.
Adrenal Gland Immunofluorescence
Adult adrenal glands were processed as described and then cryosectioned at 12
micrometers and stored at -20 degrees C until stained. Slides were stained with antibody as
previously described. Sections were allowed to dry at room temperature, circled with a
hydrophobic barrier pen, rehydrated in PBS for 20 minutes at room temperature, blocked in
blocking solution (5% w/v dry nonfat milk, 0.3% v/v Triton X-100, 0.02% sodium azide, in
PBS) for 30 minutes at room temperature. Primary rabbit anti-Pnmt antibody (polyclonal rabbit
anti-Pnmt from Sigma – product SAB2701157) was added to fresh blocking solution (1:100
dilution) and sections were incubated for 1 hour at room temperature and then 12-16 hours at 4
degrees Celsius in a humidified chamber. After incubation with the primary antibody, sections
were washed 3x10 min in PBS at room temperature. Secondary antibody (polyclonal goat antiRabbit IgG – AlexaFluor 647 from Molecular Probes product A-21245) was incubated in
blocking solution (1:200 dilution) for 2 hours at room temperature in a dark humidified chamber.
DAPI was included in the secondary antibody solution. Sections were washed 3x10 minutes in
10

PBS at room temperature then mounted in FluoroGel aqueous mounting medium (Electron
Microscopy Sciences). After slides hardened at room temperature, they were imaged.
All sections were imaged in the same manner on a Zeiss 710 confocal microscope using a
Plan-Apochromat 20x/0.8 M27 objective. Image acquisition settings for the DAPI, eGPF, and
Pnmt channels can be found in Table 1.
Table 1: Confocal Microscope Acquisition Settings for Pnmt Threshold Imaging

Laser (nm) and power (%)
Master Gain
Emission Filter
Pinhole (μm)

DAPI
405 (2.0%)
550
410-469
27

eGFP
488 (2.0%)
750
493-549
31

Pnmt
633 (4.0%)
800
650-740
41

Beam Splitter

MBS -405

MBS 488/543/633

MBS 488/543/633

% Adrenal Gland Area Expressing Threshold Level of Pnmt
The entire adrenal medulla was sectioned and the two median medullary sections were
stained. The Pnmt channel of 20X images of adrenal glands was processed in ImageJ (Schneider
et al., 2012). RGB stacks were converted to 8-bit images, inverted, and the same threshold was
set to each image. The threshold was set as the highest value that reduced background noise in
the adrenal cortex without compromising signal from the adrenal medulla (highest signal to noise
ratio). The percent area expressing a threshold level of Pnmt was calculated by creating a ROI
and measuring the percent of ROI area that met threshold fluorescence in each adrenal medulla.
The average of 20 ROI’s were taken for each section and the two median medullary sections
were averaged to give the value for one adrenal gland.
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Quantitation of Catecholamines by HPLC
Adult adrenal glands were snap-frozen in 300 uL of 0.2 M perchloric acid and shipped to
our collaborators in Porto, Portugal, where they underwent alumina oxide extraction and
subsequent HPLC with electrochemical detection. Detailed methods for the quantitation of
adrenaline and noradrenaline in adrenal glands have been previously described (MoreiraRodrigues et al., 2014).
Grip Strength Measurements
Mice underwent grip-strength testing at 6 months. Grip-strength test was performed in a
consistent manner by trained personnel on a BIO-GS3 grip strength testing device (Bioseb).
First, strength in forelimbs was recorded on four consecutive trials, followed by four consecutive
trials of all limbs. The average of all four trials was used to represent each mouse. Grip strength
was normalized to mouse body mass to account for the weight differences between groups.
Statistical Analysis
Statistical analysis of results between two groups was performed using student’s T-test or
analysis of variance (ANOVA), where appropriate. ANOVA was performed by Graphpad Prism
software using the Bonferroni correction for multiple comparisons. P-value less than 0.05 was
required to reject the null hypothesis. Data are presented as the mean ± standard error.
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RESULTS
Generation of Pnmt+/Cre; R26+/DTA Mice
The generation of Pnmt-Cre mice has been previously described. These mice have Crerecombinase inserted into the starting region of exon 1, as shown in Figure 4A. Cre-recombinase
is followed by a stop sequence; therefore, Cre-recombinase is under transcriptional control of the
Pnmt promoter region and Pnmt is not expressed from this site. Mice homozygous for Crerecombinase, denoted PnmtCre/Cre, do not express the adrenaline biosynthetic enzyme Pnmt and
lack adrenaline. Mice heterozygous for Cre-recombinase, denoted Pnmt+/Cre, have one wild type
allele and express Pnmt at this wild type allele and Cre-recombinase from the other allele. The
Rosa26-eGFP-DTA mice were purchased from the Jackson Laboratory (product #006331).
These mice have been previously described and are used to ablate cells in a Cre-dependent
manner (Ivanova et al., 2005).
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Figure 4: Schematic of Genetic Constructs
A) Pnmt-Cre construct, B), ROSA26-eGFP-DTA construct, and C) Product of Cre-recombinase at Rosa26 locus in
ROSA26-eGFP-DTA mice. Cre-mediated recombination at LoxP sites of the Rosa26 locus results in removal of the
upstream triple SV40 polyadenylation sequence and of eGFP. Consequently, Cre-recombinase activity in Pnmt+
cells results in loss of eGFP expression and activation of DTA expression.

As shown in Figure 4B, which depicts the Rosa26-eGFP-DTA construct prior to the
introduction of Cre-recombinase, the Diphtheria Toxin alpha gene (DTA) is preceded by a floxed
eGFP and triple SV40 polyadenylation sequence, a strong transcriptional terminator. eGFP is
expressed constitutively in all cells in the absence of Cre-recombinase and the DTA gene is not
transcribed due to the upstream SV40 polyadenylation sequence. Figure 4C depicts the Rosa26
locus following Cre-recombinase activity, in which the floxed eGFP and SV40 sequence have
been removed, resulting in loss of eGFP expression and activation of DTA expression.
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To generate Pnmt+/Cre; R26+/DTA mice, PnmtCre/Cre males were bred with R26+/DTA females.
This cross is expected to generate 50% Pnmt+/Cre; R26+/DTA mice (ablation groups) and 50%
Pnmt+/Cre; R26+/+ mice (control group), or 25% male and 25% female for each genotype. Table 2
depicts the observed frequency of mice that lived to age of weaning (approximately 21 days).
The expected frequency of males and females in each group is 25%, yet the observed frequency
of Pnmt+/Cre; R26+/DTA females was 15.4%. Chi squared analysis was performed to test whether
these observed ratios deviated significantly from the expected ratios (25% of each sex in each
group). It was found that there was a sex-linked deviation from expected mendelian ratios. That
is, among the Pnmt+/Cre; R26+/DTA group, there were 47 males and 23 females and this deviation
from expected values was found to be statistically significant with p value = 0.0028. There was
no statistically significant deviation from expected values within the control Pnmt+/Cre; R26+/+
group (p=0.2499). The relative percent of each genotype by sex is displayed in Table 2.
Table 2: Frequency of Viable Pups at Weaning From PnmtCre/Cre x R26+/DTA Matings.
The two possible genotypes are listed with the number of viable pups for each sex at age of weaning. Only Pnmt+/Cre;
R26+/DTA females deviated greatly from the expected 25%. This discrepancy was found to be statistically significant
by Chi squared distribution test (**p=0.0028) for Male v Female amongst Pnmt+/Cre; R26+/DTA offspring.

Male

Female

Pnmt+/Cre; R26+/+

28.9% (43/149)

24.2% (36/149)

Pnmt+/Cre; R26+/DTA

31.5% (47/149)

15.4% (23/149)**

Characterization of Adrenal Gland Contents of Pnmt+/Cre; R26+/DTA Mice
Pnmt Gene Expression in Pnmt+/Cre; R26+/DTA Mice
The results of Pnmt gene expression analysis in 6-month-old adrenal glands are depicted
in Figure 5. Pnmt mRNA levels were 97.6% lower in the adrenal glands of Pnmt+/Cre; R26+/DTA
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mice compared to those of Pnmt+/Cre; R26+/+ mice. Furthermore, Pnmt mRNA levels were 37.9%
higher in the adrenal glands of R26+/DTA mice compared to those of Pnmt+/Cre; R26+/+, but the
difference was not statistically significant (p=0.119). Pnmt+/Cre; R26+/+ mice have one wild-type
allele for Pnmt and their catecholamine concentrations have been previously reported and did not
differ from wild-type mice (Ebert et al., 2004).

Figure 5: RT-PCR Analysis of Pnmt mRNA Expression in Mouse Adrenal Glands

Quantitation of Pnmt+ Area by Immunofluorescent Staining
Using immunofluorescent staining techniques, Pnmt+ cells were identified in the adrenal
medulla of Pnmt+/Cre; R26+/+ and Pnmt+/Cre; R26+/DTA mice at P3.5. A typical Pnmt+/Cre; R26+/+
control adrenal gland for postnatal day 3 pup is shown in Figure 6A, with a closeup in Figure 6E,
and a typical Pnmt+/Cre; R26+/DTA adrenal gland is shown in Figure 6B, with a closeup in Figure
6F. Pnmt+ cells were also identified at 6 months of age in Pnmt+/Cre; R26+/+ and Pnmt+/Cre;
R26+/DTA. A 6 month old Pnmt+/Cre; R26+/+ adrenal gland is shown in Figure 6C, with a closeup in
16

Figure 6G, and a 6 month old Pnmt+/Cre; R26+/DTA adrenal gland is shown in Figure 6D, with a
closeup in Figure 6H. Pnmt is colored red and the nuclei were stained with DAPI, shown in blue.

Figure 6: Immunofluorescent Analysis of Pnmt+ Area in Early Postnatal and Adult Adrenal Glands
Pnmt immunofluorescence in P3.5 (A, B, closeups in E, F) and 6 month adrenal glands (C, D, clcoseups in G, H) in
Pnmt+/Cre; R26+/+ and Pnmt+/Cre; R26+/DTA. (I) Decreased % area meeting threshold fluorescence within the adrenal
gland at P3.5. (J) Decreased % area meeting threshold fluorescence in adrenal gland at 6 months.

The relative area of adrenal medulla expressing Pnmt protein was markedly reduced in
P3.5 and 6-month-old adrenal glands of Pnmt+/Cre; R26+/DTA mice. At postnatal day 3.5, the
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percent of medulla area expressing Pnmt was decreased by 77.7% compared to controls
(5.42±1.17, n=6 v 24.28±1.78, n=6, p<0.0001), as shown in Figure 6I. At 6 months, the percent
of medulla area expressing Pnmt was decreased by 55.8% compared to controls (21.02±3.519,
n=10 v 47.61±3.462, n=9, p<0.0001), as shown in Figure 6J.
Pnmt+, eGFP- cells were identified in 6-month-old adrenal glands in the Pnmt+/Cre;
R26+/DTA mice. The white arrows of Figure 7D denote Pnmt+ cells in red and Figure 7C shows
that these same cells do not express eGFP. The Pnmt+, eGFP- cells also express tyrosine
hydroxylase (TH), depicted in white in Figure 7B. As shown in the overlay, Figure 7E, Pnmt+,
TH+, eGFP- cells are surrounded by Pnmt-, TH-, eGFP+ cells in the adrenal gland. These
Pnmt+, TH+, eGFP- cells are likely at a timepoint after Cre-mediated recombination removed
the floxed eGFP and upstream SV40 polyadenylation sequence at the Rosa26 locus and are
expected to undergo apoptosis due to activation of DTA expression.
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Figure 7: GFP is Not Expressed in Pnmt+ Cells, but is Expressed in Surrounding Pnmt- Cells
(A) DAPI labels nuclei in blue. (B) Tyrosine Hydroxylase (TH) in white. (C) GFP in green. (D) Pnmt in red. (E)
Overlay of all channels. White arrows point to three Pnmt+, TH+, GFP- cells.

Quantitation of Catecholamine Contents in Pnmt+/Cre; R26+/DTA Mice
Whole adult adrenal glands were homogenized in perchloric acid. Catecholamines were
extracted by alumina oxide and separated by HPLC, followed by electrochemical detection. The
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total adrenaline content is depicted in Figure 8A and the total noradrenaline content is depicted
in Figure 8B.

Figure 8: HPLC for Adrenaline and Noradrenaline content of Adult Adrenal Glands
(A) Total adrenaline in adult adrenal glands. (B) Total noradrenaline in adult adrenal glands.

Adrenaline is significantly reduced in Pnmt+/Cre; R26+/DTA and Pnmt KO adrenals. The
adrenaline levels did not differ significantly between the Pnmt+/Cre; R26+/DTA group and Pnmt
knockout group. Both groups had significantly lower adrenaline content than the Pnmt+/+;
R26+/DTA control group. The Pnmt+/Cre; R26+/DTA adrenal gland had comparable levels of
noradrenaline to Pnmt+/+; R26+/DTA adrenals. The Pnmt knockout adrenals had significantly more
noradrenaline than both groups, which is expected and in agreement with previous reports due to
build-up of noradrenaline in cells that would normally be adrenergic (Ebert et al., 2004; MoreiraRodrigues et al., 2014). These results suggest that Pnmt+/Cre; R26+/DTA adrenal glands lack Pnmt+
cells that produce adrenaline, because the adrenaline content was comparable to knockouts. In
contrast with Pnmt knockout adrenal glands, Pnmt+/Cre; R26+/DTA adrenals do not build up
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noradrenaline. Pnmt knockout effectively converts adrenergic cells to a noradrenergic phenotype
and noradrenaline builds up in these cells. In the Pnmt+/Cre; R26+/DTA mouse, adrenergic cells are
killed, resulting in adrenaline levels comparable to knockout levels, but noradrenaline levels
remain physiological.

Figure 9: HPLC for Adrenaline and Noradrenaline in Adult Plasma
(A) HPLC for adrenaline in Pnmt+/Cre; R26+/+, Pnmt+/Cre; R26+/DTA, and PnmtCre/Cre (Pnmt KO) adrenal glands.
PnmtCre/Cre was below the limit of detection and represented as baseline. (B) HPLC for noradrenaline in all three
mouse genotypes. No significant differences.

Figure 9A depicts the levels of adrenaline in adult mouse plasma in the three groups
tested. Adrenaline in the Pnmt KO was baseline. Adrenaline was significantly lower in the
Pnmt+/Cre; R26+/DTA group and the Pnmt KO group. Adrenaline was not significantly different
between the Pnmt+/Cre; R26+/DTA group and Pnmt KO group. Noradrenaline was not significantly
different between any of the groups, as shown in Figure 9B. Because noradrenaline was
significantly higher in the adrenal glands of the Pnmt KO group, but not in the plasma of these
mice, it is possible that circulating noradrenaline levels only drastically increase in response to
certain stimuli, such as stress, but this is unclear at this time.
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Taken together, these data provide support for the hypothesis that crossing PnmtCre/Cre
males with R26+/DTA females produces Pnmt+/Cre; R26+/DTA mice that have severely reduced
number of Pnmt+ cells in the adrenal gland. These mice had significantly reduced Pnmt
transcript, decreased number of Pnmt+ cells in the adrenal medulla, and had significantly
reduced adrenaline stored in their adrenal glands and in circulation. Furthermore, the
identification of Pnmt+, eGFP- cells surrounded by Pnmt-, eGFP+ cells in the adrenal medulla
suggests that the genetic construct is working, since eGFP was not expressed in Pnmt+ cells.
Cardiovascular Phenotype of Pnmt+/Cre; R26+/DTA Mice
Pnmt+/Cre; R26+/DTA Mice Have Diminished LV Function
To test the functional effects Pnmt+ cell ablation, echocardiography of Pnmt+/Cre;
R26+/DTA mice was performed on a monthly basis for 6 months. Pnmt+/Cre; R26+/DTA mice
exhibited bradycardia at all timepoints, as depicted in Figure 10A.
Furthermore, ejection fraction, stroke volume, and cardiac output were significantly
reduced at all timepoints, as shown in Figures 10B, 10C, and 10D, respectively. These data are
summarized in Table 3.
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Table 3: Summary of Monthly Echocardiographic Data

1 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

N=26

N=24

Heart Rate (BPM)

428 ± 8

Stroke Volume (μL)

2 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

p-value

N=11

N=7

400 ± 8

0.019

440 ± 11

35 ± 1

31 ± 1

0.04

Ejection Fraction (%)

67 ± 2

57 ± 2

Fractional Shortening (%)

37 ± 1

30 ± 1

Cardiac Output (mL/min)

15 ± 1

Systolic Diameter (μm)

2.3 ± 0.1

Diastolic Diameter (μm)

3.6 ± 0.1

3 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

p-value

N=15

N=10

p-value

412 ± 7

0.085

442 ± 10

383 ± 7

<0.001

35 ± 2

28 ± 3

0.035

39 ± 2

25 ± 2

<0.001

<0.001

64 ± 3

51 ± 5

0.033

60 ± 3

49 ± 3

0.029

<0.001

35 ± 2

26 ± 4

0.054

32 ± 2

24 ± 2

0.022

13 ± 1

0.006

16 ± 1

12 ± 1

0.011

17 ± 1

10 ± 1

<0.001

2.6 ± 0.1

0.007

2.4 ± 0.1

2.7 ± 0.2

0.209

2.7 ± 0.1

2.7 ± 0.2

0.967

3.6 ± 0.1

0.431

3.6 ± 0.1

3.6 ± 0.2

0.985

3.9 ± 0.1

3.5 ± 0.2

0.042

4 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

N=18

N=14

Heart Rate (BPM)

447 ± 9

Stroke Volume (μL)

5 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

p-value

N=17

N=12

387 ± 9

<0.001

452 ± 8

41 ± 1

27 ± 2

<0.001

Ejection Fraction (%)

63 ± 2

51 ± 2

Fractional Shortening (%)

34 ± 2

26 ± 1

Cardiac Output (mL/min)

18 ± 1

Systolic Diameter (μm)
Diastolic Diameter (μm)

6 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

p-value

N=18

N=12

p-value

410 ± 13

0.005

477 ± 11

388 ± 15

<0.001

43 ± 1

30 ± 1

<0.001

42 ± 2

29 ± 2

<0.001

0.001

66 ± 2

52 ± 3

<0.001

66 ± 2

53 ± 5

<0.001

0.002

36 ± 2

27 ± 2

<0.001

36 ± 1

28 ± 3

0.013

11 ± 1

<0.001

19 ± 1

12 ± 1

<0.001

20 ± 1

11 ± 1

<0.001

2.6 ± 0.1

2.6 ± 0.1

0.738

2.5 ± 0.1

2.7 ± 0.1

0.114

2.4 ± 0.1

2.6 ± 0.1

0.278

3.9 ± 0.1

3.5 ± 0.1

<0.001

3.9 ± 0.1

3.7 ± 0.1

0.090

3.8 ± 0.1

3.6 ± 0.1

0.125
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Figure 10: Echocardiography Reveals Left Ventricular Dysfunction in Pnmt+/Cre; R26+/DTA Mice
(A) Heart rate was decreased in Pnmt+/Cre; R26+/DTA compared to Pnmt+/Cre; R26+/+ at all timepoints. (B) Ejection
fraction was lower at all timeptoints. (C) Stroke volume was lower at all timepoints. (D) Cardiac output, the product
of heart rate and stroke volume, was lower at all timepoints.

To test whether the decrease in left ventricular function was due to loss of Pnmt+ cells or
to the loss of circulating adrenaline, Pnmt KO mice underwent echocardiography at 5 months of
age. Pnmt KO mice lack adrenaline and their LV function did not differ from Pnmt+/Cre; R26+/+
mice. This is consistent with another report of Pnmt KO mice (Bao et al., 2007). Pnmt+/Cre;
R26+/DTA mice had significantly diminished LV function compared to Pnmt KO mice. Ejection
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fraction, stroke volume, and cardiac output were significantly decreased in the Pnmt+/Cre;
R26+/DTA group compared to the Pnmt KO group at 5 months of age, as shown in Figures 11B,
11C, and 11D. Heart rate was not significantly decreased in the Pnmt+/Cre; R26+/DTA group
compared to Pnmt KO. Table 4 summarizes the echocardiographic data of these 3 types of mice
at 5 months of age.

Figure 11: Pnmt+/Cre: R26+/DTA mice have significantly reduced LV function compared to Pnmt KO mice at 5 months.
Pnmt KO mice do not differ from Pnmt +/Cre: R26+/+. LV function was significantly lower in Pnmt+/Cre; R26+/DTA
compared to Pnmt KO and Pnmt+/Cre; R26+/+, but Pnmt KO did not differ from Pnmt+/Cre; R26+/+ for all parameters.
(A) Heart rate. (B) Ejection fraction (C) Stroke volume (D) Cardiac output.
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Table 4: Summary of Echocardiographic Analysis of Pnmt KO, Pnmt+/Cre; R26+/+, and Pnmt+/Cre: R26+/DTA at 5
Months.
**0.05<p<0.01, ***0.01<p<0.001 from Pnmt+/Cre; R26+/+, ″ 0.05<p<0.01, ‴ 0.01<p<0.001 from Pnmt KO
5 Month
Pnmt+/Cre;
R26+/+

Pnmt +/Cre;
R26+/DTA

Pnmt KO

N=17

N=12

N=7

Heart Rate (BPM)

452 ± 8

410 ± 13″

423 ± 6

Stroke Volume (μL)

43 ± 1

30 ± 1***‴

41 ± 3

Ejection Fraction (%)

66 ± 2

52 ± 3***″

65 ± 4

Fractional Shortening (%)

36 ± 2

27 ± 2***″

35 ± 3

Cardiac Output (mL/min)

19 ± 1

12 ± 1***″

18 ± 1

Systolic Diameter (μm)

2.5 ± 0.1

2.7 ± 0.1

2.5 ± 0.1

Diastolic Diameter (μm)

3.9 ± 0.1

3.7 ± 0.1

3.8 ± 0.0

Pnmt+/Cre; R26+/DTA Mice Recover Normal LV Function During Stress
To test whether Pnmt+ cells are involved in mediating the normal response to stress, we
performed echocardiography in conscious, restrained mice. Restraint stress, or immobilization
(IMO), mimics a mild stressor in mice, as they are prevented from performing the righting reflex.
Surprisingly, Pnmt+/Cre; R26+/DTA mice exhibited the same relative change in all parameters of
left ventricular function from baseline to 1 hour IMO as the Pnmt+/Cre; R26+/+ controls. As shown
in the M-modes in Figure 12, the LV is hypokinetic in Pnmt+/Cre; R26+/DTA mice at baseline (top
right). There is little movement of the left ventricular posterior wall (LVPW, white arrow) and
the interventricular septum (IVS) exhibits little contraction during systole (red arrow). After one
hour and two hours of immobilization, the LVPW and IVS exhibit faster, more forceful
contractions.
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Figure 12: Representative M-Mode Images of the Left Ventricle Parasternal Long Axis during IMO
Pnmt+/Cre; R26+/+ (left column) and Pnmt+/Cre; R26+/DTA (right column) at Baseline (top row), and at One Hour
(middle row) and Two Hours (bottom row) of Immobilization. Heart rate and contractility of the IVS (red arrow)
and LVPW (white arrow) are hypokinetic at baseline, but increase substantially in response to stress in Pnmt +/Cre;
R26+/+ controls and in Pnmt+/Cre; R26+/DTA mice.

As shown in Figure 13, Pnmt+/Cre; R26+/DTA mice exhibit the same general trend as
Pnmt+/Cre; R26+/+ control mice during IMO. During stress, Pnmt+/Cre; R26+/DTA mice responded
with increased heart rate and increased ejection fraction, in a manner similar to controls. Stroke
volume decreased due to the decrease in diastolic diameter during IMO and this lea to the
decrease in cardiac output in both groups.
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Figure 13: Pnmt+/Cre; R26+/DTA Mice Display Normal Stress Response to Immobilization
Baseline, 1 Hour, and 2 Hour analysis of echocardiography. (A) Heart rate, (B) Ejection fraction, (C) Stroke volume,
(D) Cardiac output, (E) Diastolic diameter, and (F) Systolic diameter.
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Pnmt+/Cre; R26+/DTA Mice Fail to Gain Weight into Adulthood
Pnmt+/Cre; R26+/DTA mice appear normal at weaning compared to Pnmt+/Cre; R26+/+
littermate controls and R26+/DTA controls. By 4 months, Pnmt+/Cre; R26+/DTA males have
significantly reduced body mass, as shown in Figure 14, and by 5 months, females have
significantly reduced body mass, as shown in Figure 15. Despite providing soft food on the floor
of cages (Dietgel, Hydrogel, and moist food pellets), these mice fail to gain body mass and
become emaciated. One male was found dead and one female was sacrificed due to emaciation at
3 months, and one male and one female were sacrificed due to emaciation at 5 months.

Figure 14: Lack of Weight Gain in Males

Figure 15: Lack of Weight Gain in Females
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Pnmt+/Cre; R26+/DTA Mice Exhibit Symptoms of Neurological Dysfunction
An unexpected result of this study was the development of clear neuromuscular
dysfunction in these mice. Pnmt+/Cre; R26+/DTA mice generally appeared normal at weaning (P21),
but by 2-3 months of age, many began to exhibit hind limb clasping, altered gait, and kyphosis,
indicators of neuromuscular dysfunction (Guyenet et al., 2010). By 5-6 months of age, 100% of
Pnmt-Cre/DTA mice exhibit these phenotypes.
Figure 16A depicts the normal tail suspension reflex, in which both feet are held apart for
the duration of the suspension test (approximately 10 seconds) and Figure 16B depicts the
pathological leg splay, in which both legs clasp tightly upon immediately starting the test.

Figure 16: Hind Leg Clasping During Tail Suspension Reflex Test
(A) Pnmt+/Cre; R26+/+ controls exhibit normal tail suspension reflex, in which both legs are directed away from the
abdomen. (B) Leg clasping in Pnmt+/Cre: R26+/DTA mice.

The gait was clearly disturbed in these mice and they exhibited kyphosis, or hunched
back. Kyphosis was present while walking and while standing still.
Grip strength was measured in 6-month-old adult mice. Grip strength of the forelimbs
(Fig 17A) and in both limbs (Fig 17B) was significantly lower in Pnmt+/Cre: R26+/DTA compared
to Pnmt+/Cre: R26+/+.
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Figure 17: Decreased Grip Strength in Pnmt+/Cre; R26+/DTA mice
(A) Forelimb grip strength is significantly lower in Pnmt +/Cre; R26+/DTA. (B) Grip strength of all limbs is significantly
lower in Pnmt+/Cre; R26+/DTA.
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DISCUSSION
Here, we showed for the first time that selective destruction of Pnmt+ cells results in
significantly reduced cardiac function at rest, lack of normal weight gain, and neuromuscular
dysfunction in Pnmt+/Cre; R26+/DTA mice. Breeding PnmtCre/Cre mice with Rosa26-eGFP-DTA
mice produced Pnmt+/Cre; R26+/DTA mice that had significantly reduced Pnmt transcript, reduced
Pnmt immunoreactive area in the adrenal glands, and adrenaline levels that are comparable to
Pnmt knockout mice. Pnmt+/Cre; R26+/DTA mice exhibited left ventricular dysfunction at rest, but
Pnmt knockout mice did not. These results suggest that Pnmt+ cells are required for normal
cardiovascular function, but adrenaline is not. Pnmt+ cell ablation also seems to
disproportionally affect the number of females that survive to weaning, or 21 days. Further
investigation is needed to assess these effects in females and whether this result is due to death in
utero or during the early postnatal period.
Pnmt+ Cells of the Adult Heart
It has previously been shown that Pnmt+ cells contribute to development of the adult
myocardium by becoming cardiomyocytes, intracardiac neurons, and intrinsic cardiac adrenergic
cells (Ebert et al., 2004) (Osuala et al., 2011) (Slavikova et al., 2003) (Huang et al., 1996). Since
adrenaline deficiency alone (in the Pnmt KO) does not recapitulate the phenotype of Pnmt+/Cre;
R26+/DTA mice, these cells likely contribute to basal cardiovascular function in a manner other
than the secretion of adrenaline. In left ventricular myocardium, cardiomyocytes derived from
Pnmt+ cells are likely being killed off and this may be the cause of the LV dysfunction.
Histological examination of Pnmt+/Cre; R26+/DTA hearts is expected to shed insight to the cause of
the LV dysfunction.
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Additionally, Pnmt immunoreactivity has been identified in the SA node of developing
hearts (Ebert and Taylor, 2006). Pnmt+/Cre; R26+/DTA mice exhibit bradycardia at rest, but Pnmt
KO mice do not (Bao et al., 2007). Thus, Pnmt+ cells likely play a major role in establishing the
rate of cardiac pacing, since this discrepancy cannot be attributed to adrenaline alone.
It is remarkable that Pnmt+/Cre; R26+/DTA mice exhibited such robust response to
immobilization stress. These mice, which had adrenaline levels close to knockout and had
noradrenaline levels comparable to controls, responded to stress by increased heart rate and
increased ejection fraction. These rapid responses to stress are likely mediated by the actions of
noradrenaline at the Beta1 adrenergic receptor. The Beta1 adrenergic receptor is the major
receptor responsible for increased heart rate in response to exercise-induced stress (Rohrer et al.,
1999; Rohrer and Kobilka, 1998) (Chruscinski et al., 1999). Beta2 adrenergic receptor knockout
mice display the normal exercise-induced tachycardia, but Beta1 adrenergic receptor knockout
mice do not. The Pnmt+/Cre; R26+/DTA mice exhibit bradycardia at rest, yet responded to stress
with increased heart rate, but their heart rate was still significantly lower than controls during
stress.
Furthermore, studies are currently underway to better distinguish the hormonal effects of
adrenergic agonists in Pnmt+/Cre; R26+/DTA mice. If the left ventricular dysfunction is due to loss
of ventricular myocardium, and not from a lack of adrenergic receptor stimulation, then these
mice should display the same phenotype in the presence of continuous agonism of adrenergic
receptors at physiological levels. To test this hypothesis, we have begun a “rescue” experiment,
where mice are given a modest level of nonselective beta and alpha adrenergic receptor agonist
in the drinking water at weaning. (-)Isoproterenol is a nonselective beta adrenergic receptor
agonist and L-phenylephrine is a nonselective alpha receptor agonist. Together, this concoction
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of adrenergic receptor agonists rescues DBH knockout mice from heart failure (Thomas et al.,
1998). DBH knockout mice lack adrenaline and noradrenaline and die of apparent heart failure in
utero (Thomas et al., 1995). Infusion of (-) isoproterenol and L-phenylephrine can rescue DBH
knockouts to term, suggesting that these drugs properly mimic the physiological actions of the
absent hormones, noradrenaline and adrenaline. If the LV dysfunction is due to lack of sufficient
adrenergic receptor stimulation, it is expected that the concoction of (-) isoproterenol and Lphenylephrine will not result in normal LV function.
Pnmt+ Cells Contribute to Neuromuscular Function
The severe neuromuscular dysfunction was unexpected in these mice. The current
literature describing the role of Pnmt in locomotion is sparse. Studies using pharmacological
inhibitors of Pnmt found decreased locomotor activity (Katz et al., 1978). Pnmt activity has been
detected in cerebellum, at the same time that adrenaline levels begin to rise (Diaz Borges et al.,
1980) (Diaz Borges and Chavez, 1980). Two forms of Pnmt mRNA have been detected in
cerebellum (Andreassi et al., 1998). The effects of Pnmt knockout and adrenaline deficiency on
neuromuscular function have not previously been published. Here, we report that the destruction
of Pnmt+ cells results in severe ataxia, kyphosis, and hind limb clasping at an early age.
Thus far, no published reports indicate a role of Pnmt+ neurons or other Pnmt+ cell type
in the maintenance of neuromuscular function. It is unlikely that adrenaline release from these
cells is primarily responsible for their function, since Pnmt KO does not lead to any observable
ataxia. It is possible that Pnmt is expressed transiently in certain subpopulations of cells that
contribute to normal motor behavior, or that these neurons act primarily through some other
neurotransmitter and express Pnmt at low levels. Others have suggested a role of adrenergic

34

neurons in modulating dopaminergic neurons of the extrapyramidal tract, but functional and
anatomical evidence has been lacking (Katz et al., 1978). Our data warrant further investigation
into the role of Pnmt+ cells in neural control of motor function.
Pnmt+ Cells in Appetite Control or Metabolism
Pnmt+/Cre; R26+/DTA mice became severely emaciated at five to six months of age.
Whether this severe lack of weight gain is secondary to heart failure or the result of altered
feeding behavior or disturbed metabolic function has yet to be determined. Pnmt knockout mice
do not have perturbed body mass or food intake, but do have decreased lean mass and increased
body fat percentage (Sharara-Chami et al., 2010). Pnmt+ axons projecting from the brain stem to
the paraventricular nucleus (PVN) of the hypothalamus have been identified (Rinaman, 2001).
Additionally, electrolytic lesions to the PVN were shown to induce hyperphagia and obesity
(Leibowitz et al., 1981) and noradrenaline injection directly to the PVN has been shown to
stimulate preprandial drinking and feeding in satiated rats (Leibowitz, 1978). It is possible that
Pnmt+ projections modulate PVN, reducing PVN activity, and leading to activation of appetite.
Studies currently underway will help discern whether ablation of Pnmt+ cells reduces weight
gain through dysregulation of appetite and feeding behavior or through metabolic dysregulation.
Pnmt has also been identified in adipocytes, and their destruction cannot be ruled out as a
mechanism of weight loss in these mice (Kvetnansky et al., 2012).
The results of this study support the literature reports of Pnmt expression in extra-adrenal
tissue. The functional consequences of Pnmt+ cell ablation resulted in significantly diminished
LV function, reduced weight gain, and severe symptoms of cerebellar ataxia. These symptoms
were present in adolescence and progressively worsened into adulthood. The role of the cells that
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mediate these effects is not likely through secretion of adrenaline, since the Pnmt knockout does
not produce similar phenotypes. Overall, these results provide functional evidence for the role of
Pnmt+ cells in normal cardiovascular function. Furthermore, Pnmt+ cells may also play a role in
neuromuscular function and may be involved in appetite stimulation.
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APPENDIX: PERMISSION FOR REPRINT OF FIGURE 2
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